FINASTERIDE MABO 1 mg FILM-COATED TABLETS EFG

2. What you need to know before taking Finasteride MABO

Do not take Finasteride MABO:

• if you are a woman (because this medication is for men, see section Pregnancy). Clinical trials have shown that finasteride is not effective in women with hair loss.
• if you are allergic to the active ingredient (finasteride) or to any of the other components of this medication (listed in section 6).

Warnings and Precautions

Consult your doctor or pharmacist before starting to take this medication.

Effects on Prostate-Specific Antigen (PSA)

Finasteride may affect a blood test called PSA (Prostate-Specific Antigen) for detecting prostate cancer. If you have had a PSA test, you should inform your doctor or pharmacist that you are taking Finasteride MABO, as it decreases PSA levels.

Effects on Fertility

Infertility has been reported in men who took finasteride for a long time and had other risk factors that could affect fertility. Normalization or improvement of semen quality has been reported after discontinuing finasteride treatment. No long-term clinical studies have been conducted on the effect of finasteride on male fertility.

Breast Cancer

See section 4.

Mood Changes and Depression

Mood changes, such as depressed mood, depression, and, less frequently, suicidal thoughts have been reported in patients treated with this medication. If you experience any of these symptoms, stop taking finasteride and consult your doctor as soon as possible for medical advice.

Children and Adolescents

Finasteride should not be used in children. There are no data to demonstrate the efficacy and safety of finasteride in children under 18 years old.

Taking Finasteride MABO with Other Medications

Inform your doctor or pharmacist if you are taking, have recently taken, or may take any other medication.

Pregnancy, Breastfeeding, and Fertility

Finasteride is intended for the treatment of male pattern hair loss exclusively in males. For effects on fertility in men, see section 2.

• Women should not use finasteride due to the risk of pregnancy.
• Pregnant women should not handle crushed or broken finasteride tablets.
• If a pregnant woman with a male fetus absorbs the active ingredient of finasteride after ingesting it orally or through the skin, her son may be born with genital anomalies.
• If a pregnant woman comes into contact with the active ingredient of finasteride, she should consult a doctor.
• The finasteride tablets are film-coated to prevent contact with the active ingredient during normal handling.

In case of doubt, ask your doctor.

Driving and Using Machines

There are no data to indicate that this medication affects the ability to drive or use machines.

Finasteride MABO contains Lactose

This medication contains lactose. If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.

Finasteride MABO contains Sodium

This medication contains less than 23 mg of sodium (1 mmol) per unit dose; it is essentially "sodium-free".

3. How to Take Finasteride MABO

Follow the exact instructions for administration of this medication as indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.

The recommended dose is one tablet per day. The tablets can be taken with or without food.

Your doctor will help you determine if Finasteride MABO is effective in your case. It is essential to take Finasteride MABO for the entire time your doctor indicates. Finasteride MABO only works in the long term if its administration is maintained.

If you take more Finasteride MABO than you should

If you take too many tablets by mistake, go to the doctor immediately. Finasteride MABO will not work faster or better by taking more than one tablet per day.

Consult your doctor, pharmacist, or call the Toxicology Information Service, phone 91 562 04 20, indicating the medication and the amount taken. It is recommended to take the package and package leaflet of the medication to the healthcare professional.

If you forget to take Finasteride MABO

Do not take a double dose to make up for forgotten doses.

If you stop taking Finasteride MABO

To appreciate the effect, it may be necessary to take the medication for 3 to 6 months. It is essential that you try to take Finasteride MABO for the entire period indicated by your doctor. If you stop taking Finasteride MABO, you will likely lose the hair you gained in the 9 to 12 months following treatment discontinuation.

If you have any other questions about the use of this medication, ask your doctor or pharmacist.

4. Possible Side Effects

Like all medications, this medication can cause side effects, although not everyone gets them.

Side effects have been, normally, transient with continued treatment or have disappeared when treatment is discontinued.

Stop taking finasteride and inform your doctor immediately if you experience any of the following symptoms: swelling of the lips, face, tongue, and throat; difficulty swallowing; lumps under the skin (hives) and difficulty breathing.

You should inform your doctor immediately of any change in breast tissue, such as lumps, pain, breast tissue enlargement, or nipple discharge, as these may be signs of a serious disease, such as breast cancer.

Uncommon: may affect up to 1 in 100 people

• decreased sexual desire
• difficulty achieving an erection
• problems with ejaculation, including a decrease in the amount of semen ejaculated
• depression

Frequency not known: frequency cannot be estimated from available data

• allergic reactions including rash and itching
• breast tenderness and enlargement
• testicular pain
• rapid heartbeat
• persistent difficulty having an erection after stopping treatment
• persistent decrease in sexual desire after stopping treatment
• persistent ejaculation problems after stopping treatment
• male infertility and/or poor semen quality
• elevated liver enzymes
• anxiety

Reporting Side Effects:

If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect not listed in this package leaflet. You can also report them directly through the Spanish Medication Surveillance System for Human Use: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.

5. Storage of Finasteride MABO

Keep this medication out of sight and reach of children.

Do not use this medication after the expiration date stated on the package after CAD. The expiration date is the last day of the month indicated.

This medication does not require special storage conditions.

Medications should not be disposed of through wastewater or household waste. Deposit the packages and medications you no longer need in the SIGRE collection point at the pharmacy. In case of doubt, ask your pharmacist how to dispose of the packages and medications you no longer need. This way, you will help protect the environment.

6. Package Contents and Additional Information

Composition of Finasteride MABO

• The active ingredient is finasteride. Each tablet contains 1 mg of finasteride.
• The other components are:

Core of the tablet: lactose monohydrate, microcrystalline cellulose, pregelatinized corn starch, sodium carboxymethyl cellulose (type A, potato), sodium docusate, and magnesium stearate.

Coating:Opadry Brown 03A86790 (talc, hypromellose 2910/HPMC (E-464), titanium dioxide (E-171), yellow iron oxide (E-172), and red iron oxide (E-172).

Appearance of the Product and Package Contents

• Finasteride MABO film-coated tablets are provided in blisters.
• The tablets are film-coated, round, brown, engraved with 'H' on one side and '36' on the other.
• Package sizes: 28 or 98 tablets.
• Not all package sizes may be marketed.

Marketing Authorization Holder and Manufacturer

Marketing Authorization Holder

MABO-FARMA S.A.

Calle Vía de los Poblados 3,

Edificio 6, 28033, Madrid,

Spain.

Manufacturer

Pharmadox Healthcare Ltd.

KW20A Kordin Industrial Park

Paola PLA 3000

Malta

Date of the Last Revision of this Package Leaflet: July 2019

Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/)